Tempest Therapeutics Inc. (TPST) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Tempest Therapeutics Inc.

NASDAQ: TPST · Real-Time Price · USD
10.40
-0.37 (-3.44%)
At close: Oct 03, 2025, 3:59 PM
10.50
0.96%
Pre-market: Oct 06, 2025, 05:34 AM EDT

Tempest Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
30.27M 39.23M 31.23M 51.83M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
388K n/a n/a n/a
Other Long-Term Assets
97K 448K 429K 111K
Receivables
n/a n/a 450K 15M
Inventory
n/a n/a n/a n/a
Other Current Assets
535K 96K 263K 553K
Total Current Assets
31.47M 40.36M 32.95M 68.96M
Property-Plant & Equipment
9.53M 10.79M 12.71M 4.16M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
10.01M 11.24M 13.14M 4.28M
Total Assets
41.49M 51.6M 46.09M 73.24M
Account Payables
2.45M 845K 1.11M 991K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
6.35M 4.29M n/a n/a
Other Current Liabilities
n/a 1.79M 2.1M 13.56M
Total Current Liabilities
14.22M 9.41M 7.28M 20.03M
Long-Term Debt
n/a 6.26M 10.37M 15.07M
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
8.14M 15.42M 20.7M 17.09M
Total Liabilities
22.36M 24.84M 27.98M 37.12M
Total Debt
15.37M 20.66M 22.11M 18.54M
Book Value
19.13M 26.77M 18.11M 36.12M
Book Value Per Share
0.69 1.74 20.40 124.11
Common Stock
44K 22K 11K 7K
Retained Earnings
-207.11M -165.26M -135.77M -100.06M
Comprehensive Income
n/a n/a n/a -73.24M
Shareholders Equity
19.13M 26.77M 18.11M 36.12M
Total Investments
388K 388K n/a n/a